Colorectal Cancer Ppts and latest 100 published articles

Colorectal Cancer
www.medicine.emory.edu/

Describe the various treatment options. Colorectal Cancer.
www.pitt.edu

Colorectal Cancer Screening
www.medicine.wisc.edu/

COLON CANCER SCREENING Current Recommendations
http://medicine.med.miami.edu/

Colon Cancer - UCCS
https://www.uccs.edu

Biomarkers of obesity and risk of colon cancer
www.ph.ucla.edu/

Chemoprevention of colorectal cancer
http://depts.washington.edu/

Colon & Rectum Questions

http://www.meddean.luc.edu/

Colorectal Cancer Screening in Adults Under 50
www.downstate.edu

Descriptive Epidemiology and Burden of Colorectal Cancer (CRC)
https://medicine.missouri.edu

Colon Cancer
https://aecom.yu.edu/

Colonoscopy - Faculty Web Sites at the University of Virginia
https://faculty.virginia.edu

Inherited Susceptibility to Cancer
www.med.umich.edu

Familial Cancer Syndromes
www.med.umich.edu/

Oncology Nursing
https://facweb.northseattle.edu

Genetics of Cancer
www.uvm.edu/ 

Virtual Colonoscopy: Preferred Colorectal Cancer Screening ...
www.uky.edu

Latest published articles of Colorectal Cancer

1.    Zhu, D., et al., ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras-ERK signaling. J Cell Physiol, 2018.
2.    Zhang, Z., et al., Analysis of differentially expressed circular RNAs for the identification of a coexpression RNA network and signature in colorectal cancer. J Cell Biochem, 2018.
3.    Zhang, Y., et al., Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Curr Probl Cancer, 2018.
4.    Zhang, T., et al., Comparative Epidemiological Investigation of Alzheimer's Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD. Front Aging Neurosci, 2018. 10: p. 176.
5.    Zhang, L., et al., An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis. J Cell Biochem, 2018.
6.    Yu, T., et al., Oral Administration of Liposome-Apatinib and Locally Delivery of Docetaxel/MPEG-PCL by Fibrin Glue Synergistically Improve Therapeutic Effect in Colorectal Cancer. J Biomed Nanotechnol, 2018. 14(12): p. 2077-2091.
7.    Ye, Z., et al., A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer. J Natl Compr Canc Netw, 2018. 16(10): p. 1183-1192.
8.    Yang, Y., et al., Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer. Cancer Manag Res, 2018. 10: p. 3911-3929.
9.    Yang, M., et al., Afatinib treatment for her-2 amplified metastatic colorectal cancer based on patient-derived xenograft models and next generation sequencing. Cancer Biol Ther, 2018: p. 1-6.
10.    Yang, D., et al., miR3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2. Mol Med Rep, 2018.
11.    Yang, C., et al., Prognostic value of pre- and post-operative circulating tumor cells detection in colorectal cancer patients treated with curative resection: a prospective cohort study based on ISET device. Cancer Manag Res, 2018. 10: p. 4135-4144.
12.    Xu, G., Y. Zhou, and F. Zhou, Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I-III patients with colorectal cancer after operation. Cancer Manag Res, 2018. 10: p. 4051-4064.
13.    Wu, X., et al., Radix Tetrastigma hemsleyani flavone exhibits antitumor activity in colorectal cancer via Wnt/beta-catenin signaling pathway. Onco Targets Ther, 2018. 11: p. 6437-6446.
14.    Wu, W., et al., (+)-Usnic Acid Inhibits Migration of c-KIT Positive Cells in Human Colorectal Cancer. Evid Based Complement Alternat Med, 2018. 2018: p. 5149436.
15.    Woo, H.T., et al., Regional differences in colorectal cancer mortality between 2000 and 2013 in Republic of Korea. J Epidemiol, 2018.
16.    Williams, S.P., et al., Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer. Sci Data, 2018. 5: p. 180215.
17.    Wierdak, M., et al., Use of inflammatory markers in the early detection of infectious complications after laparoscopic colorectal cancer surgery with the ERAS protocol. Wideochir Inne Tech Maloinwazyjne, 2018. 13(3): p. 315-325.
18.    Weldon Gilcrease, G., et al., Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer. Invest New Drugs, 2018.
19.    Weinstein, A.M., et al., Association of IL-36gamma with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer. Cancer Immunol Immunother, 2018.
20.    Wei, N., et al., Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis. Clin Transl Oncol, 2018.
21.    Warner, E.L., et al., A Workplace-Based Intervention to Improve Awareness, Knowledge, and Utilization of Breast, Cervical, and Colorectal Cancer Screenings Among Latino Service and Manual Labor Employees in Utah. J Community Health, 2018.
22.    Wang, X., et al., A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer. BMC Cancer, 2018. 18(1): p. 962.
23.    Wang, W., et al., Dietary and the Risk of Sporadic Colorectal Cancer in China: A Case-control Study. Iran J Public Health, 2018. 47(9): p. 1327-1335.
24.    van der Waals, L.M., I.H.M. Borel Rinkes, and O. Kranenburg, ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer. PLoS One, 2018. 13(10): p. e0205536.
25.    Vaccaro, C.A., et al., From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America. Int J Cancer, 2018.
26.    Uzunparmak, B. and I.H. Sahin, Comment on "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer". Br J Cancer, 2018. 119(7): p. 908.
27.    Tong, G., et al., The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study. Cancer Med, 2018.
28.    Sun, X., et al., A novel discriminating colorectal cancer model for differentiating normal and tumor tissues. Epigenomics, 2018.
29.    Smith, T., et al., The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study. Br J Cancer, 2018.
30.    Shinagawa, T., et al., Pine-cone and villi patterns are endoscopic signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia. Gastrointest Endosc, 2018.
31.    Shima, Z.M., et al., A molecular basis for the synergy between 17allylamino17demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression. Gene, 2018.
32.    Shigematsu, Y., et al., Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis. BMC Cancer, 2018. 18(1): p. 980.
33.    Shepshelovich, D., et al., Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. Cancer Med, 2018.
34.    Schoenfeld, P., Evidence-Based Guidelines for Screening Individuals With a Family History of Colorectal Cancer: More Questions than Answers. Gastroenterology, 2018.
35.    Ratjen, I., et al., Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors. Int J Cancer, 2018.
36.    Rasmussen, M., C. Platell, and M. Jones, Monitoring excess unplanned return to theatre following colorectal cancer surgery. ANZ J Surg, 2018.
37.    Qu, A., et al., Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans. EBioMedicine, 2018.
38.    Polli, J.R., F.A. Engler, and J.P. Balthasar, Physiologically-based modeling of the pharmacokinetics of "catch-and-release" anti-carcinoembryonic antigen monoclonal antibodies in colorectal cancer xenograft mouse models. J Pharm Sci, 2018.
39.    Pinar, I., et al., Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer. Ann Surg Oncol, 2018.
40.    Nowakowski, M., et al., Postoperative complications are associated with worse survival after laparoscopic surgery for non-metastatic colorectal cancer - interim analysis of 3-year overall survival. Wideochir Inne Tech Maloinwazyjne, 2018. 13(3): p. 326-332.
41.    Ni, S., et al., CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer. Cancer Med, 2018.
42.    Mologni, L., Synergistic activity of dasatinib in combination with beta-catenin blockade in colorectal cancer cells. Eur J Cancer, 2018.
43.    Manfredi, S., C. Lepage, and J. Faivre, Very high-risk individuals for colorectal cancer: Local oncologic networks are critically needed! Dig Liver Dis, 2018.
44.    Mai, T.T.X., et al., Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program. Yonsei Med J, 2018. 59(9): p. 1034-1040.
45.    Luo, Y., et al., Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway. Cancer Lett, 2018. 440-441: p. 11-22.
46.    Liu, Z., et al., NFIB Promotes Colorectal Cancer Cell Proliferation, EMT and 5-Fluorouracil Resistance. Cancer Sci, 2018.
47.    Liu, X., et al., DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/beta-catenin signal pathways. Cell Death Dis, 2018. 9(10): p. 1037.
48.    Liu, P.H., et al., Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women. JAMA Oncol, 2018.
49.    Liu, L., et al., HLTF suppresses the migration and invasion of colorectal cancer cells via TGFbeta/SMAD signaling in vitro. Int J Oncol, 2018.
50.    Lindberg, L.J., et al., Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition. Fam Cancer, 2018.
51.    Lin, C., et al., Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer. Digestion, 2018: p. 1-7.
52.    Liang, L., et al., An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients. Cell Physiol Biochem, 2018. 50(2): p. 768-782.
53.    Li, Q., et al., Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells. J Cell Biochem, 2018.
54.    Li, H., et al., Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells. Mol Carcinog, 2018.
55.    Lee, L.Y., et al., SERUM- AND GLUCOCORTICOID-INDUCED KINASE SGK1 DIRECTLY PROMOTES THE DIFFERENTIATION OF COLORECTAL CANCER CELLS AND RESTRAINS METASTASIS. Clin Cancer Res, 2018.
56.    Lavoie, S. and W.S. Garrett, The Story Unfolds: ATF6, Microbial Dysbiosis, and Colorectal Cancer. Gastroenterology, 2018.
57.    Lam, T.H., et al., Recommendations on prevention and screening for colorectal cancer in Hong Kong. Hong Kong Med J, 2018. 24(5): p. 521-526.
58.    Kumar, N.A.N., et al., Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes. J Surg Oncol, 2018.
59.    Krakowska, M., et al., The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy. Prz Gastroenterol, 2018. 13(3): p. 218-222.
60.    Kosinsky, R.L., et al., Loss of RNF40 decreases NF-kappaB activity in colorectal cancer cells and reduces colitis burden in mice. J Crohns Colitis, 2018.
61.    Kam, A.E., et al., Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials. Invest New Drugs, 2018.
62.    Jin, H., et al., A new chalcone derivative, 3-phenyl-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-yn-1-one), inhibits phorbol ester-induced metastatic activity of colorectal cancer cells through upregulation of heme oxygenase-1. Eur J Pharmacol, 2018.
63.    Huang, L., et al., Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. J Cell Physiol, 2018.
64.    Hu, Y., et al., Enhanced uptake and improved anti-tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer. Int J Pharm, 2018. 552(1-2): p. 319-327.
65.    Hiyoshi, Y., et al., CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer. Int J Clin Oncol, 2018.
66.    Hinger, S.A., et al., Diverse Long RNAs Are Differentially Sorted into Extracellular Vesicles Secreted by Colorectal Cancer Cells. Cell Rep, 2018. 25(3): p. 715-725 e4.
67.    Heller, D.R., et al., Regional Differences in Palliative Care Utilization Among Geriatric Colorectal Cancer Patients Needing Emergent Surgery. J Gastrointest Surg, 2018.
68.    Haug, U., [Current evidence and development of colorectal cancer screening in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2018.
69.    Hatfield, E., et al., Impact of colonoscopic screening in Familial Colorectal Cancer Type X. Mol Genet Genomic Med, 2018.
70.    Hassan, C. and A. Repici, Morphological and Histological Risk Factors for T1 Colorectal Cancer: Friends or Enemies? Clin Gastroenterol Hepatol, 2018.
71.    Han, E.C., et al., Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis. Ann Surg Treat Res, 2018. 95(4): p. 201-212.
72.    Hamada, T., et al., Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells. J Natl Cancer Inst, 2018.
73.    Guo, Y., F. Chen, and W. Cui, Usefulness of plasma D-dimer level for monitoring development of distant organ metastasis in colorectal cancer patients after curative resection. Cancer Manag Res, 2018. 10: p. 4203-4216.
74.    Green, B.B., Colorectal Cancer Control: Where Have We Been and Where Should We Go Next? JAMA Intern Med, 2018.
75.    Ghadban, T., et al., Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade. Sci Rep, 2018. 8(1): p. 15146.
76.    Gendler, S., et al., Urgent Laparotomy in Patients with Metastatic Colorectal Cancer Presenting as an Acute Abdomen: A Retrospective Analysis. Isr Med Assoc J, 2018. 20(10): p. 619-622.
77.    Gallo, G., Preoperative Colorectal-Cancer Detection: Do We Need Anything Else? An Invited Brief Commentary on Is CT Scan More Accurate than Endoscopy in Identifying Distance from the Anal Verge for Left-sided Colon Cancer? A Comparative Cohort Analysis. J Invest Surg, 2018: p. 1-2.
78.    Gabel, P., et al., The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial. Trials, 2018. 19(1): p. 543.
79.    Fischer, J., et al., Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity? Antioxidants (Basel), 2018. 7(10).
80.    Fang, W., et al., Cruciferous vegetables and colorectal cancer risk: a hospital-based matched case-control study in Northeast China. Eur J Clin Nutr, 2018.
81.    Falk, H., et al., [How many patients had their colon investigated within five years prior to colorectal cancer diagnosis?]. Lakartidningen, 2018. 115.
82.    Dube, C., Organized Screening Is Better Than Opportunistic Screening at Decreasing the Burden of Colorectal Cancer in the United States. Gastroenterology, 2018.
83.    Dougherty, M.K., et al., Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis. JAMA Intern Med, 2018.
84.    Ding, L., et al., Downregulation of cyclooxygenase1 stimulates mitochondrial apoptosis through the NFkappaB signaling pathway in colorectal cancer cells. Oncol Rep, 2018.
85.    Degett, T.H., et al., Mortality after emergency treatment of colorectal cancer and associated risk factors-a nationwide cohort study. Int J Colorectal Dis, 2018.
86.    Degeling, K., et al., Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients. Cancer Epidemiol, 2018. 57: p. 60-67.
87.    Deding, U., C. Torp-Pedersen, and H. Boggild, The association between immigration status and ineligible stool samples for colorectal cancer screening. Cancer Epidemiol, 2018. 57: p. 74-79.
88.    Cruz-Ramos, M., et al., Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer. J Geriatr Oncol, 2018.
89.    Clarke, W.T. and J.D. Feuerstein, After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality. Ann Intern Med, 2018. 169(8): p. JC38.
90.    Bolzacchini, E., et al., Isolated diaphragmatic metastasis from resected colorectal cancer. Dig Liver Dis, 2018.
91.    Bennedsen, A.L.B., J.R. Eriksen, and I. Gogenur, Prolonged hospital stay and readmission rate in an ERAS cohort undergoing colorectal cancer surgery. Colorectal Dis, 2018.
92.    Bartolome, R.A., M. Jaen, and J.I. Casal, An IL13Ralpha2 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer, 2018.
93.    Bakkenist, C.J., J.J. Lee, and J.C. Schmitz, ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer. Clin Colorectal Cancer, 2018.
94.    Abelson, J.S., et al., Coping strategies among colorectal cancer patients undergoing surgery and the role of the surgeon in mitigating distress: A qualitative study. Surgery, 2018.
95.    Abbasian, M., et al., The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis. J Cell Physiol, 2018.
96.    Colorectal Cancer Prevention. Am J Gastroenterol, 2018.
97.    Clinical Vignettes/Case Reports - Colorectal Cancer Prevention. Am J Gastroenterol, 2018.
98.    Erratum: Long Y, Sanchez-Espiridion B, Lin M, et al. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2018;124: 785-796. Cancer, 2018. 124(17): p. 3621.